I also know someone who's significantly better now than they were a few years ago thanks to alzheimer's medication. And Trontinemab, which is currently in phase III trials I believe, seems even better than what is publicly available as it crosses the blood-brain barrier more readily. We're entering a brighter future for alzheimer's patients.
No comments yet.